Bias in CFTR screening panels
- PMID: 26513347
- PMCID: PMC4816068
- DOI: 10.1038/gim.2015.105
Bias in CFTR screening panels
Conflict of interest statement
DISCLOSURE
The authors declare no conflict of interest.
Comment in
-
Response to Sosnay et al.Genet Med. 2016 Feb;18(2):209-10. doi: 10.1038/gim.2015.106. Epub 2015 Oct 29. Genet Med. 2016. PMID: 26513348 No abstract available.
Comment on
-
Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk.Genet Med. 2016 Feb;18(2):174-9. doi: 10.1038/gim.2015.52. Epub 2015 Apr 16. Genet Med. 2016. PMID: 25880441
References
-
- Lim RM, Silver AJ, Silver MJ, et al. Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk. Genet Med. e-pub ahead of print 16 April 2015. - PubMed
-
- Grody WW, Thompson BH, Gregg AR, et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med. 2013;15:482–483. - PubMed
-
- Dorfman R, Nalpathamkalam T, Taylor C, et al. Do common in silico tools predict the clinical consequences of amino-acid substitutions in the. CFTR gene? Clin Genet. 2010;77:464–473. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
